Is a complete CNSP research report available?

No complete published report is available for CNS Pharmaceuticals, Inc. (CNSP) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CNS Pharmaceuticals, Inc. (CNSP)

NASDAQ: CNSP · USD

$4.50

-0.58 (-11.4%)· Recorded snapshot

Market cap	6.6M
Net income (ttm)	-16.7M
EPS (ttm)	-$7.66
Shares out	1.5M
Volume	60,443
Beta	1.02

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -16.7M
EPS (ttm): -$7.66
Market cap: 6.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Metric	Value
Amount currency	USD
CIK code	0001729427
Company name	CNS Pharmaceuticals, Inc.
Country	United States
Country code	US
CUSIP number	18978H508
Earnings date	2026-11-16
Earnings time	bmo
Employees	8
Employees change	3
Employees growth	60%
Enterprise value	$-13.4M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2017
Industry	Biotechnology
IPO date	2019-11-08
Is primary listing	Yes
Is SPAC	No
ISIN number	US18978H5081
Last 10-K release date	2026-03-31
Last earnings date	2026-08-12
Last refreshed	2026-10-28
Last stock split date	2025-07-22
Last stock split type	Reverse
Market cap	$6.6M
Market cap category	Nano-Cap
Next earnings date	2026-11-16
Options	No
Price	$4.50
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	CNSP
U.S. state	Texas
Website	https://cnspharma.com

Metric

Value

Amount currency

USD

CIK code

0001729427

Company name

CNS Pharmaceuticals, Inc.

Country

United States

Country code

CUSIP number

18978H508

Earnings date

2026-11-16

Earnings time

bmo

Employees

Employees change

Employees growth

60%

Enterprise value

$-13.4M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2017

Industry

Biotechnology

IPO date

2019-11-08

Is primary listing

Yes

Is SPAC

ISIN number

US18978H5081

Last 10-K release date

2026-03-31

Last earnings date

2026-08-12

Last refreshed

2026-10-28

Last stock split date

2025-07-22

Last stock split type

Reverse

Market cap

$6.6M

Market cap category

Nano-Cap

Next earnings date

2026-11-16

Options

Price

$4.50

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

CNSP

U.S. state

Texas

Website

https://cnspharma.com

Metric	Value
Earnings yield	-170.15%
FCF / EV yield	107.01%
FCF yield	-181.05%
P/B ratio	0.41x
Price / tangible book value	0.41x
Sector forward P/E	23.53x
Sector P/E	51.01x

Metric

Value

Earnings yield

-170.15%

FCF / EV yield

107.01%

FCF yield

-181.05%

P/B ratio

0.41x

Price / tangible book value

0.41x

Sector forward P/E

23.53x

Sector P/E

51.01x

Metric	Value
Profit per employee	$-2.1M
ROA	-58.01%
ROA (5Y)	-123.07%
ROCE	-92.94%
ROE	-106.62%
ROE (5Y)	-675.26%
ROIC	-67.23%

Metric

Value

Profit per employee

$-2.1M

ROA

-58.01%

ROA (5Y)

-123.07%

ROCE

-92.94%

ROE

-106.62%

ROE (5Y)

-675.26%

ROIC

-67.23%

Metric	Value
EPS growth quarters	2
EPS growth years	5
Net income growth years	0
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$-28,175
Depreciation and amortization	$14,918
EBIT	$-16.9M
EBITDA	$-16.9M
EPS	$-7.66
FCF per share	$-9.20
Financing cash flow	$21.3M
Free cash flow	$-13.4M
Free cash flow minus SBC	$-13.6M
Investing cash flow	$-28,175
Net borrowing	$-308,553
Net cash flow	$7.9M
Net income	$-16.7M
Operating cash flow minus SBC	$-13.5M
Operating income	$-16.9M
Stock-based compensation	$108,728

Metric

Value

Capital expenditures

$-28,175

Depreciation and amortization

$14,918

EBIT

$-16.9M

EBITDA

$-16.9M

EPS

$-7.66

FCF per share

$-9.20

Financing cash flow

$21.3M

Free cash flow

$-13.4M

Free cash flow minus SBC

$-13.6M

Investing cash flow

$-28,175

Net borrowing

$-308,553

Net cash flow

$7.9M

Net income

$-16.7M

Operating cash flow minus SBC

$-13.5M

Operating income

$-16.9M

Stock-based compensation

$108,728

Metric	Value
Book value per share	$12.45
Debt / equity	0
Interest coverage	-1,110.61
Long-term assets	$15,000
Long-term liabilities	$0
Net cash (debt)	$20M
Net cash / market cap	269.19%
Net cash growth	66.43%
Net debt / equity	-1.1
Piotroski F-Score	1
Property, plant and equipment	$15,000
Shareholders' equity	$18.2M
Tangible book value	$18.2M
Tangible book value per share	$12.45
Total assets	$21.9M
Total cash	$20M
Total debt	$0
Total liabilities	$3.7M
WACC	9.85%

Metric

Value

Book value per share

$12.45

Debt / equity

Interest coverage

-1,110.61

Long-term assets

$15,000

Long-term liabilities

Net cash (debt)

$20M

Net cash / market cap

269.19%

Net cash growth

66.43%

Net debt / equity

-1.1

Piotroski F-Score

Property, plant and equipment

$15,000

Shareholders' equity

$18.2M

Tangible book value

$18.2M

Tangible book value per share

$12.45

Total assets

$21.9M

Total cash

$20M

Total debt

Total liabilities

$3.7M

WACC

9.85%

Metric	Value
Current assets	$21.9M
Current liabilities	$3.7M
Current ratio	5.86
Net working capital	$-1.8M
Quick ratio	5.35
Working capital	$18.2M

Metric

Value

Current assets

$21.9M

Current liabilities

$3.7M

Current ratio

5.86

Net working capital

$-1.8M

Quick ratio

5.35

Working capital

$18.2M

Metric	Value
Buyback yield / dilution	-1,105.07%
Dividend yield	0%
Shareholder yield	-1,105.07%

Metric

Value

Buyback yield / dilution

-1,105.07%

Dividend yield

Shareholder yield

-1,105.07%

Metric	Value
150-day SMA	$4.75
1D price change	-11.42%
1M price change	2.41%
1M total return	2.41%
1W price change	1.2%
1W total return	1.2%
1Y price change	-39.52%
1Y return CAGR	-39.54%
1Y total return	-39.52%
20-day SMA	$5.12
200-day SMA	$4.61
3M price change	-0.39%
3M total return	-0.39%
3Y price change	-99.99%
3Y return CAGR	-95.53%
3Y total return	-99.99%
50-day SMA	$5.41
50-day SMA vs 200-day SMA	50over200
52-week high	$10.54
52-week high date	2026-05-04
52-week low	$1.90
52-week low date	2026-04-22
5Y price change	-100%
5Y return CAGR	-91.6%
5Y total return	-100%
6M price change	120.52%
6M total return	120.52%
All-time high	$5,120,961.21
All-time high date	2019-11-19
All-time low	$1.90
All-time low date	2026-04-22
Average true range (ATR)	$0.50
Average volume	11.4K
Beta (1Y)	4.76
Beta (2Y)	3.52
Beta (5Y)	1.02
Change from 52-week high	-57.31%
Change from 52-week low	136.84%
Change from all-time high	-100%
Change from all-time low	165.79%
Change from open	4.65%
Day's gap	-15.35%
Dollar volume	$271,994
High price	$5.15
Low price	$4.30
Monthly RSI	24.95
Open price	$4.30
Position in 52-week range	23.53%
Premarket change	0%
Premarket close	$5.08
Premarket price	$5.08
Previous close	$5.08
Price vs 150-day SMA	6.32%
Price vs 20-day SMA	-1.33%
Price vs 200-day SMA	9.45%
Price vs 50-day SMA	-6.57%
Relative volume	5.3
Return from IPO open	-100%
Return from IPO price	27%
RSI	47.98
Sharpe ratio	0.39
Sharpe ratio (3Y)	-0.99
Sharpe ratio (5Y)	-0.63
Sortino ratio	1.78
Sortino ratio (3Y)	-1.76
Sortino ratio (5Y)	-1.27
Volume	60.4K
Weekly RSI	38.33
YTD price change	-3.81%
YTD total return	-3.81%

Metric

Value

150-day SMA

$4.75

1D price change

-11.42%

1M price change

2.41%

1M total return

2.41%

1W price change

1.2%

1W total return

1.2%

1Y price change

-39.52%

1Y return CAGR

-39.54%

1Y total return

-39.52%

20-day SMA

$5.12

200-day SMA

$4.61

3M price change

-0.39%

3M total return

-0.39%

3Y price change

-99.99%

3Y return CAGR

-95.53%

3Y total return

-99.99%

50-day SMA

$5.41

50-day SMA vs 200-day SMA

50over200

52-week high

$10.54

52-week high date

2026-05-04

52-week low

$1.90

52-week low date

2026-04-22

5Y price change

-100%

5Y return CAGR

-91.6%

5Y total return

-100%

6M price change

120.52%

6M total return

120.52%

All-time high

$5,120,961.21

All-time high date

2019-11-19

All-time low

$1.90

All-time low date

2026-04-22

Average true range (ATR)

$0.50

Average volume

11.4K

Beta (1Y)

4.76

Beta (2Y)

3.52

Beta (5Y)

1.02

Change from 52-week high

-57.31%

Change from 52-week low

136.84%

Change from all-time high

-100%

Change from all-time low

165.79%

Change from open

4.65%

Day's gap

-15.35%

Dollar volume

$271,994

High price

$5.15

Low price

$4.30

Monthly RSI

24.95

Open price

$4.30

Position in 52-week range

23.53%

Premarket change

Premarket close

$5.08

Premarket price

$5.08

Previous close

$5.08

Price vs 150-day SMA

6.32%

Price vs 20-day SMA

-1.33%

Price vs 200-day SMA

9.45%

Price vs 50-day SMA

-6.57%

Relative volume

5.3

Return from IPO open

-100%

Return from IPO price

27%

RSI

47.98

Sharpe ratio

0.39

Sharpe ratio (3Y)

-0.99

Sharpe ratio (5Y)

-0.63

Sortino ratio

1.78

Sortino ratio (3Y)

-1.76

Sortino ratio (5Y)

-1.27

Volume

60.4K

Weekly RSI

38.33

YTD price change

-3.81%

YTD total return

-3.81%

Metric	Value
Float	1.3M
Float percentage	90.08%
Shares change (QoQ)	911.31%
Shares change (YoY)	1,105.07%
Shares held by insiders	0.62%
Shares held by institutions	13.54%
Shares outstanding	1.5M
Short % of float	0.07%
Short % of shares	0.06%
Short ratio	0.2 days

Metric

Value

Float

1.3M

Float percentage

90.08%

Shares change (QoQ)

911.31%

Shares change (YoY)

1,105.07%

Shares held by insiders

0.62%

Shares held by institutions

13.54%

Shares outstanding

1.5M

Short % of float

0.07%

Short % of shares

0.06%

Short ratio

0.2 days

CNS Pharmaceuticals, Inc. (CNSP)

Price

Financial snapshot

Fair-value bridge

Latest news · CNSP

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CNSP indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CNSP

Frequently asked questions